Brind.
  1. China's biotech sector is driving global deal flow, while US Congress proposes required Treasury review of investments.

The Chinese Communist Party competes in the biotechnology sector with state support.

1 report, 1 independent Updated May 19
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

The Chinese Communist Party competes in the biotechnology sector with state support.

Who's involved

What this event is mainly about

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped